176 related articles for article (PubMed ID: 36415513)
1. Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation.
Javanshir HT; Malekraeisi MA; Ebrahimi SSS; Bereimipour A; Kashani SF; Bostaki AA; Mahmoodzadeh H; Nayernia K
J Med Life; 2022 Sep; 15(9):1143-1157. PubMed ID: 36415513
[TBL] [Abstract][Full Text] [Related]
2. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
Shi H; Xu H; Chai C; Qin Z; Zhou W
J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
Zheng X; Liu X; Zheng H; Wang H; Hong D
Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
[TBL] [Abstract][Full Text] [Related]
5. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.
Bai R; Rebelo A; Kleeff J; Sunami Y
Lipids Health Dis; 2021 Jun; 20(1):58. PubMed ID: 34078402
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
9. Predicting novel salivary biomarkers for the detection of pancreatic cancer using biological feature-based classification.
Liu HJ; Guo YY; Li DJ
Pathol Res Pract; 2017 Apr; 213(4):394-399. PubMed ID: 28283209
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
11. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
12. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
Lu Y; Li C; Chen H; Zhong W
Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
[TBL] [Abstract][Full Text] [Related]
14. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
Xu JS; Liao KL; Wang X; He J; Wang XZ
J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
[TBL] [Abstract][Full Text] [Related]
15.
Deng Y; Ma H; Hao J; Xie Q; Zhao R
Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
18. Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.
Zhu T; Gao YF; Chen YX; Wang ZB; Yin JY; Mao XY; Li X; Zhang W; Zhou HH; Liu ZQ
Oncotarget; 2017 Mar; 8(13):21281-21289. PubMed ID: 28177904
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Important Molecular Pathways and Candidate Diagnostic Biomarkers of Noninvasive to Invasive Stages in Gastric Cancer by In Silico Analysis.
Tutunchi S; Akhavan S; Bereimipour A; Hossein Ghaderian SM
J Oncol; 2021; 2021():5571413. PubMed ID: 34054953
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
Li J; Tan W; Peng L; Zhang J; Huang X; Cui Q; Zheng J; Tan W; Wu C; Lin D
Cancer Commun (Lond); 2018 Apr; 38(1):13. PubMed ID: 29764514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
